People · Operator
Named in public records as an officer, director or promoter · active 2016–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| toSense, Inc. | — | Biotechnology | Seed | $8.1M | $33.3M | 2016 |
Susan Pede at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Susan Pede on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Hell | 1 | 4 |
| Carl Melcher | 1 | 2 |
| Matt Banet | 1 | 2 |
| Aaron Tankersley | 1 | 2 |
| Rory Moore | 1 | 2 |
| Gregory Feld | 1 | 1 |
| Carl Hartzel | 1 | 1 |
| John Melcher | 1 | 1 |
| Craig Collins | 1 | 1 |
| Dhillon Marshal | 1 | 1 |
| Greg Feld | 1 | 1 |
| Peter Georgianna | 1 | 1 |
| Matthew Banet | 1 | 1 |
| Alton Shader | 1 | 1 |
| Robert W Cass | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.